Biphenyl

Biphenyl

SCHEMBL7414261

O=C(Oc1ncc[nH]1)c1ccccc1[N+](=O)[O-].c1ccc(-c2ccccc2)cc1

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.51
NPC1 O15118 4/20 0.47
RAB9A P51151 4/20 0.47
ALDH1A1 P00352 5/20 0.45
MAPT P10636 3/20 0.45
HTT P42858 2/20 0.43
KDM4E B2RXH2 3/20 0.41
TDP1 Q9NUW8 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
NCOA1 Q15788 1/20 0.40
NCOA3 Q9Y6Q9 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
CTSD P07339 1/20 0.39
MAPK1 P28482 1/20 0.39
MEN1 O00255 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
BCHE P06276 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL11231296 0.78 CSNK1A1 (0.44) KMT2ANPC1RAB9AALDH1A1MAPT
SCHEMBL4879110 0.76 ALDH1A1 (0.42) KMT2AALDH1A1MAPTKDM4ETDP1
SCHEMBL24485 0.74 HPGD (0.51) KMT2AALDH1A1MAPTKDM4ETDP1
SCHEMBL10438254 0.73 NPC1 (0.45) KMT2ANPC1RAB9AMAPTHTT
SCHEMBL31588107 0.72 KMT2A (0.71) KMT2ANPC1RAB9AALDH1A1MAPT
SCHEMBL17673999 0.72 KMT2A (0.71) KMT2ANPC1RAB9AALDH1A1MAPT
SCHEMBL5323575 0.72 LMNA (0.45) KMT2ARAB9AALDH1A1MAPTKDM4E
SCHEMBL8548846 0.72 KMT2A (0.60) KMT2ANPC1RAB9AALDH1A1HTT
SCHEMBL11111898 0.70 TSHR (0.58) KMT2AALDH1A1MAPTHTTTDP1
SCHEMBL19975330 0.69 KMT2A (0.59) KMT2ANPC1RAB9AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5674879-A Compositions including and methods of using conformationally restricted angiotensin II antagonist G.D. SEARLE & CO. (US) 1997-10-07 US disclosed
US-5426105-A Cardiovascular disorders G.D. SEARLE & CO. (US) 1995-06-20 US disclosed